These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37879141)
1. Pan-cancer genetic analysis of disulfidptosis-related gene set. Liu H; Tang T Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141 [TBL] [Abstract][Full Text] [Related]
2. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. Zhang K; Zhu Z; Zhou J; Shi M; Wang N; Yu F; Xu L Transl Oncol; 2024 Nov; 49():102091. PubMed ID: 39146597 [TBL] [Abstract][Full Text] [Related]
3. Disulfidptosis: A New Target for Parkinson's Disease and Cancer. Liu T; Kong X; Wei J Curr Issues Mol Biol; 2024 Sep; 46(9):10038-10064. PubMed ID: 39329952 [TBL] [Abstract][Full Text] [Related]
4. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Liu H; Tang T Front Oncol; 2022; 12():952290. PubMed ID: 36276096 [TBL] [Abstract][Full Text] [Related]
5. Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation. Zhao X; Zhao Y; Zhang Y; Fan Q; Ke H; Chen X; Jin L; Tang H; Jiang Y; Ma J J Biol Eng; 2024 Jul; 18(1):42. PubMed ID: 39061076 [TBL] [Abstract][Full Text] [Related]
6. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis. Shen LP; Jiang HT Open Med (Wars); 2024; 19(1):20240929. PubMed ID: 38584831 [TBL] [Abstract][Full Text] [Related]
7. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer. Cong Y; Cai G; Ding C; Zhang H; Chen J; Luo S; Liu J Front Genet; 2024; 15():1378907. PubMed ID: 38694875 [TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. Xie J; Deng X; Xie Y; Zhu H; Liu P; Deng W; Ning L; Tang Y; Sun Y; Tang H; Cai M; Xie X; Zou Y MedComm (2020); 2024 Mar; 5(3):e502. PubMed ID: 38420162 [TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma. Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669 [No Abstract] [Full Text] [Related]
10. Identification of disulfidptosis-related genes and subgroups in Alzheimer's disease. Ma S; Wang D; Xie D Front Aging Neurosci; 2023; 15():1236490. PubMed ID: 37600517 [TBL] [Abstract][Full Text] [Related]
11. Wang X; Zhu HQ; Lin SM; Xia BY; Xu B Transl Cancer Res; 2024 May; 13(5):2518-2534. PubMed ID: 38881923 [TBL] [Abstract][Full Text] [Related]
12. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H Front Immunol; 2024; 15():1288240. PubMed ID: 38292868 [TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer. Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532 [TBL] [Abstract][Full Text] [Related]
14. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768 [TBL] [Abstract][Full Text] [Related]
15. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. Chen X; Hu G; Yu Q Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315 [TBL] [Abstract][Full Text] [Related]
16. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients. Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324 [TBL] [Abstract][Full Text] [Related]
17. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
18. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275 [TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
20. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]